The suggested therapy for glycogen storage disease type I is to:

Question

Quizplus · Accepted Answer

Glycogen storage disease type I is caused by a deficiency in the enzyme glucose-6-phosphatase, which impairs the liver's ability to release glucose into the blood. Therefore, providing a continuous source of glucose through frequent feedings is the recommended therapy. Limiting glucose intake would further exacerbate the problem, while limiting galactose intake or providing a continuous source of galactose would not address the underlying issue of glucose release. Glycogen storage disease type I is characterized by the inability to break down glycogen into glucose, leading to low blood glucose levels. The therapy for this condition involves a continuous source of glucose through frequent feedings, typically every 3-4 hours. Limiting glucose intake would be harmful for these individuals, as they rely on a constant supply of glucose to maintain their blood sugar levels. Galactose is not a major contributor to the condition and limiting its intake is not necessary for therapy.

The Suggested Therapy for Glycogen Storage Disease Type I Is